CIVCO Announces 510(k) Clearance for Protura™ Robotic Patient Positioning System Integration with VisionRT®
CORALVILLE, Iowa, Oct. 24, 2012 /PRNewswire/ -- CIVCO Medical Solutions, the leading provider of radiation oncology motion management solutions, is pleased to announce U.S. Food and Drug Administration 510(k) clearance for Protura™ Robotic Patient Positioning System integration with AlignRT® 3D Imaging System.
"We are pleased to announce clearance to market the newest release of Protura integrated with VisionRT," said Nat Geissel, senior vice president and general manager of CIVCO's radiation oncology division. "This release allows Protura to seamlessly integrate with the AlignRT 3D surface imaging solution from VisionRT."
Protura's ability to interface with existing IGRT-enabled interfaces supports sub-millimenter patient positioning and corrections with 6 degrees of freedom. This integration allows the AlignRT user to apply calculated translation and rotational shifts automatically to the Protura system from within the simple and intuitive AlignRT interface. The Protura system provides automated, consistent and accurate 6 DOF patient alignment. Together these leading-edge technologies advance the adoption of sophisticated treatment techniques. The combination of positioning accuracy, advance technology and data consistency provided with system integration makes Protura the clinician's first choice for streamlined workflow and increased patient throughput.
CIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. CIVCO's Radiation Oncology (RO) division designs, manufactures and markets comprehensive motion management solutions to improve patient outcomes and increase clinical productivity for head & neck, breast, lung, abdomen, prostate and other treatment sites. RO's products include couchtops and overlays for linear accelerators and imaging systems, advanced patient immobilization solutions, robotic patient positioning, advanced fiducial markers, and immobilization/positioning equipment and consumables. The Multi-Modality Imaging (MMI) unit designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. MMI's products range from infection control products including a wide range of ultrasound and CT covers to device guidance, positioning and electromagnetic needle tracking. CIVCO offers patients and clinicians the newest and best technology available to improve patient care.
Corporate information is available at www.CIVCO.com.
For further information please contact:
Marketing Communications Specialist
CIVCO Medical Solutions
COPYRIGHT © 2012. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. PROTURA AND ALL OTHER TRADEMARKS ARE PROPERTY OF THEIR RESPECTIVE OWNERS. NOT ALL PRODUCTS MAY BE AVAILABLE IN ALL MARKETS. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2012C0830
SOURCE CIVCO Medical Solutions
More by this Source
CIVCO Advances Real-Time Planning for Brachytherapy with New EX3™ Stepper
Nov 20, 2013, 12:49 ET
CIVCO Names Darrell Newcombe as Vice President of International Sales for Radiation Oncology
Sep 20, 2013, 10:59 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.